What is the recommended protocol for weaning a patient off trazodone (antidepressant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone Weaning Protocol

Trazodone should be gradually reduced by decreasing the dose by 10% of the original dose every 2-4 weeks, slowing to 10% per month when reaching 30% of the original dose, to minimize withdrawal symptoms. 1, 2

Understanding Trazodone Withdrawal

Trazodone discontinuation can lead to withdrawal symptoms if stopped abruptly. The FDA label specifically states: "Gradually reduce the dosage rather than stopping Trazodone Hydrochloride Tablets abruptly whenever possible." 1

Withdrawal symptoms may include:

  • Anxiety and agitation
  • Sleep disturbances
  • Dizziness
  • Headache
  • Irritability
  • Nausea
  • Sensory disturbances

Recommended Tapering Protocol

Based on the FDA guidance and clinical guidelines for similar medications, the following tapering schedule is recommended:

  1. Initial phase: Reduce by 10% of the original dose
  2. Middle phase: Continue reducing by 10% every 2-4 weeks
  3. Final phase: When reaching 30% of the original dose, slow down to 10% reduction per month

Example Tapering Schedule for 150mg Daily Dose:

  • Week 1-4: 135mg daily (10% reduction)
  • Week 5-8: 120mg daily (20% reduction)
  • Week 9-12: 105mg daily (30% reduction)
  • Week 13-16: 90mg daily (40% reduction)
  • Week 17-20: 75mg daily (50% reduction)
  • Week 21-24: 60mg daily (60% reduction)
  • Week 25-28: 45mg daily (70% reduction)
  • Week 29-32: 30mg daily (80% reduction)
  • Week 33-36: 15mg daily (90% reduction)
  • Week 37-40: Discontinue

Monitoring During Tapering

Monitor for withdrawal symptoms during the tapering process:

  • If withdrawal symptoms occur, slow the taper or temporarily return to the previous dose
  • Consider lengthening the intervals between dose reductions if symptoms are problematic
  • For severe symptoms, a more gradual taper may be necessary

Special Considerations

Duration of Treatment

  • Patients on trazodone for less than 7 days may be able to discontinue more quickly
  • Those on trazodone for 7-14 days require a more gradual taper
  • Patients on trazodone for more than 14 days need the full gradual tapering protocol 2

Dose Timing

  • Since trazodone is often prescribed for sleep, consider maintaining the evening dose and tapering the daytime dose first if on a divided dosing schedule 1

High-Risk Patients

  • Patients with a history of withdrawal symptoms from other medications
  • Those with anxiety disorders or sleep disturbances
  • Elderly patients
  • Patients on high doses (>300mg daily)

Common Pitfalls to Avoid

  1. Tapering too quickly: Many guidelines recommend short tapers of 2-4 weeks, which may be insufficient to prevent withdrawal symptoms 2
  2. Not tapering low enough: Continue tapering to doses much lower than minimum therapeutic doses
  3. Ignoring breakthrough symptoms: If withdrawal symptoms occur, slow the taper rather than pushing through
  4. Stopping abruptly: Even at low doses, abrupt discontinuation can trigger withdrawal symptoms 1, 3

Alternative Approaches

For patients experiencing significant difficulty with tapering:

  • Consider switching to a longer half-life antidepressant before tapering
  • Adjunctive medications may help manage specific withdrawal symptoms (e.g., short-term use of benzodiazepines for severe anxiety or insomnia) 4, 5

Remember that the goal is to minimize withdrawal symptoms while successfully discontinuing the medication. A slower taper is generally safer and more comfortable for the patient than a rapid one.

References

Guideline

Baclofen Withdrawal Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mechanisms of the development of trazodone withdrawal symptoms.

International clinical psychopharmacology, 1994

Research

Trazodone in benzodiazepine dependence.

The Journal of clinical psychiatry, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.